Article
circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN…
Oxidative Medicine and Cellular Longevity · 2021 · Ling Gao, author Xian Shao, author Qingqing Yue, author Weifei Wu, author Xuejuan Yang, author Xiaolei He, author Limin Li, author Fujun Hou, author Ruonan Zhang, author Fabio Ciccarone, Academic Editor
Key facts
| Title | circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway |
|---|---|
| First author | Ling Gao, author Xian Shao, author Qingqing Yue, author Weifei Wu, author Xuejuan Yang, author Xiaolei He, author Limin Li, author Fujun Hou, author Ruonan Zhang, author Fabio Ciccarone, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Mar 8, 2021 |
| DOI | 10.1155/2021/9970272 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K973350, K990827 |
| Product codes mentioned | JCI, KIT, NDS, NJT, OOI, JLX, KQP, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1